Medical Analysis Systems, Inc.

FDA Regulatory Profile

Summary

Total Recalls
0
510(k) Clearances
107
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K042717MAS, DADE AND LIQUID ASSAYED DIABETES CONTROLNovember 5, 2004
K041194ABBOTT ARCHITECT STAT TROPONIN I LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL L, M AND HAugust 16, 2004
K040880MAS CARDIOIMMUNE TL LIQUID ASSAYED CARDIAC MARKER CONTROL, LEVELS 1,2 AND 3April 28, 2004
K032826MAS PAR TDMOctober 9, 2003
K032335MAS CARDIOIMMUNE PROBNP, MAS CARDIOIMMUNE TLAugust 19, 2003
K031890MAS BILIRUBIN LIQUID ASSAYED BILIRUBIN CONTROLJuly 16, 2003
K031392MAS TOX AMMONIA CONTROLLIQUID ASSAYED TOX AMMONIA CONTROLJuly 1, 2003
K031441URICHEMTRAK LIQUID ASSAYED URINE CONTROLJuly 1, 2003
K031364MAS CARDIOLMMUNE PROBNP LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL 1, 2 AND 3May 30, 2003
K030942MAS CHEMTRAK H & DADE MONI-TROL H LIQUID ASSAYED CHEMISTRY CONTROLApril 28, 2003
K030679MAS LIPID LEVEL 1 AND 2March 14, 2003
K023669MAS CARDIOIMMUNE TL LOW LEVEL LIQUID ASSAYED CARDIAC MARKER CONTROL, DADE CARDIAC TL LOW LEVEL LIQUIDecember 19, 2002
K023867MAS T-MARKER, LEVEL 1,2 AND 3, DADE SPECIAL-T MARKER, LEVEL 1,2 AND 3December 17, 2002
K023928MAS UA CONTROL LIQUID ASSAYED URINALYSIS CONTROL, DADE ASSAYED URINALYSIS CONTROLDecember 11, 2002
K023307MAS DIABETES CONTROL - LYOPHILIZED ASSAYED DIABETES CONTROLOctober 31, 2002
K021155MAS UA CONTROL, DADE UA CONTROL- LIQUID ASSAYED URINALYSIS CONTROLApril 29, 2002
K013995MODIFICATION TO MAS CARDIOLMMUNE TL; DADE CARDIAC TLDecember 21, 2001
K013734MAS LIPID CONTROL, LIQUID ASSAYED LIPID CONTROL, LEVEL 1 AND 2, DADE LIPID CONTROL, LIQUID ASSAYED LDecember 7, 2001
K011731TRI-POINT LIQUIMMUNE LIQUID ASSAYED CONTROL LEVELS 1,2, AND 3July 5, 2001
K011548CHEMTRAK PLATINUM COMPREHENSIVE LIQUID ASSAYED CHEMISTRY AND TDM CONTROL LEVELS 1, 2, 3June 18, 2001